Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia

Prenat Diagn. 1994 Aug;14(8):762-5. doi: 10.1002/pd.1970140819.

Abstract

We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism. This condition was successfully managed with the intra-amniotic instillation of 250 micrograms of L-thyroxine weekly, for 3 weeks. A male infant was delivered at 32 weeks by Caesarean section. The neonatal electrocardiogram showed Wolf-Parkinson-White (WPW) syndrome, which was controlled by digoxin alone. Thyroid function normalized quickly and the baby is developing normally.

MeSH terms

  • Adult
  • Amiodarone / adverse effects*
  • Amiodarone / therapeutic use
  • Digoxin / therapeutic use
  • Female
  • Fetal Diseases / drug therapy
  • Fetal Diseases / etiology*
  • Humans
  • Hypothyroidism / drug therapy
  • Hypothyroidism / etiology*
  • Infant, Newborn
  • Male
  • Pregnancy
  • Tachycardia, Supraventricular / drug therapy*
  • Thyroxine / administration & dosage
  • Thyroxine / therapeutic use
  • Wolff-Parkinson-White Syndrome / drug therapy

Substances

  • Digoxin
  • Amiodarone
  • Thyroxine